Evogene Ltd. (EVGN)
0.5076
-0.03
(-5.63%)
USD |
NASDAQ |
Sep 08, 16:00
0.5002
-0.01
(-1.46%)
After-Hours: 20:00
Evogene Debt to Equity Ratio : -0.6386 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6386 |
| March 31, 2026 | -0.798 |
| December 31, 2025 | -26.80 |
| September 30, 2025 | 2.207 |
| June 30, 2025 | -0.749 |
| March 31, 2025 | -0.7111 |
| December 31, 2024 | -1.725 |
| September 30, 2024 | -0.158 |
| June 30, 2024 | 0.2641 |
| March 31, 2024 | 0.1208 |
| December 31, 2023 | 0.0944 |
| September 30, 2023 | 0.067 |
| June 30, 2023 | 0.1035 |
| March 31, 2023 | 0.0744 |
| December 31, 2022 | 0.065 |
| September 30, 2022 | 0.063 |
| June 30, 2022 | 0.0574 |
| March 31, 2022 | 0.055 |
| December 31, 2021 | 0.0497 |
| September 30, 2021 | 0.0447 |
| June 30, 2021 | 0.0359 |
| March 31, 2021 | 0.0329 |
| December 31, 2020 | 0.053 |
| September 30, 2020 | 0.0548 |
| June 30, 2020 | 0.0658 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0617 |
| December 31, 2019 | 0.0592 |
| September 30, 2019 | 0.0576 |
| June 30, 2019 | 0.0788 |
| March 31, 2019 | 0.0672 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Compugen Ltd. | 0.0341 |
| Pluri, Inc. | -1.808 |
| Scinai Immunotherapeutics Ltd. | 0.3052 |
| CollPlant Biotechnologies Ltd. | 0.5422 |
| Regentis Biomaterials Ltd. | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 13.44M |
| Total Liabilities (Quarterly) | 4.542M |
| Shareholders Equity (Quarterly) | -3.29M |
| Current Ratio | 3.566 |
| Net Debt Paydown Yield | 1.65% |